These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7625989)

  • 1. Clinical impact of hyperprolactinaemia.
    Schlechte JA
    Baillieres Clin Endocrinol Metab; 1995 Apr; 9(2):359-66. PubMed ID: 7625989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperprolactinaemia and bone mineral density].
    Kostrzak A; Męczekalski B
    Pol Merkur Lekarski; 2015 Aug; 39(230):122-5. PubMed ID: 26319389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
    Haddad PM; Wieck A
    Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current treatment issues in female hyperprolactinaemia.
    Crosignani PG
    Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):152-64. PubMed ID: 16288952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
    Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral content in normally menstruating women with hyperprolactinaemia.
    Nyström E; Leman J; Lundberg PA; Lindquist O; Hansson T; Bengtsson C; Rybo G; Lindstedt G
    Horm Res; 1988; 29(5-6):214-7. PubMed ID: 3220459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery.
    Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinaemia and sexual function in the male.
    Bouloux PM; Grossman A
    Br J Hosp Med; 1987 Jun; 37(6):503-10. PubMed ID: 3594036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.
    Kyritsi EM; Dimitriadis GK; Angelousi A; Mehta H; Shad A; Mytilinaiou M; Kaltsas G; Randeva HS
    Eur J Clin Invest; 2018 Jul; 48(7):e12961. PubMed ID: 29845629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density and bone turnover in hyperprolactinaemia of various origins.
    Zadrozna-Sliwka B; Bolanowski M; Kałuzny M; Syrycka J
    Endokrynol Pol; 2007; 58(2):116-22. PubMed ID: 17578827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperprolactinemia and prolactinemia--investigation and treatment].
    Svartberg J; Carlsen SM; Cappelen J; Aanderud S; Johansen ML; Schreiner T; Kollevold T; Bakke S; Bollerslev J
    Tidsskr Nor Laegeforen; 2002 Feb; 122(5):494-8. PubMed ID: 11961978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinemia and infertility.
    Shibli-Rahhal A; Schlechte J
    Endocrinol Metab Clin North Am; 2011 Dec; 40(4):837-46. PubMed ID: 22108283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia.
    Meaney AM; O'Keane V
    Life Sci; 2002 Jul; 71(9):979-92. PubMed ID: 12088758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperprolactinaemia and the regular menstrual cycle in asymptomatic women: should it be treated during therapy for infertility?
    Nawroth F
    Reprod Biomed Online; 2005 Nov; 11(5):581-8. PubMed ID: 16409707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical treatment of hyperprolactinaemic disorders.
    Ferrari C; Crosignani PG
    Hum Reprod; 1986 Dec; 1(8):507-14. PubMed ID: 3546358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An audit of the diagnostic usefulness of PRL and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia.
    Sawers HA; Robb OJ; Walmsley D; Strachan FM; Shaw J; Bevan JS
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):321-6. PubMed ID: 9156042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
    O'Keane V
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.
    Holt RI
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):28-37. PubMed ID: 18477618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinaemia.
    Prabhakar VK; Davis JR
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):341-53. PubMed ID: 17889620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current treatment options for hyperprolactinemia.
    Faje A; Nachtigall L
    Expert Opin Pharmacother; 2013 Aug; 14(12):1611-25. PubMed ID: 23738973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.